Overview

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-and mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Status:
NOT_YET_RECRUITING

Trial end date:
2030-06-30

Target enrollment:

Participant gender:

Summary

This is a prospective randomized controlled Phase / Clinical study to evaluate the clinical efficacy and safety of Envafolimab combining with Cetuximab - and mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Phase:

PHASE2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

envafolimab